Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery: Discussion

Plastic and Reconstructive Surgery

Volumn 112, Issue 5 SUPPL., 2003, Pages

  Rohrich, Rod J ^a   Janis, Jeffrey E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

AGING; DENERVATION; ELECTROMYOGRAPHY; ESTHETIC SURGERY; FACE; FOOD AND DRUG ADMINISTRATION; HUMAN; NOTE; ORBICULARIS OCULI MUSCLE; PRIORITY JOURNAL; WRINKLE;

EID: 33750864255     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000082193.79684.91     Document Type: Note

References (6)

1. U.S. Food and Drug Administration. FDA approves Botox to treat frown lines (FDA Talk Paper T02-20). Available at: http://www.fda.gov.bbs/topics/ ANSWERS/2002/ANS01147.html. April 15, 2002.
2. Allergan Corporation. Botox cosmetic (botulinum toxin type A) purified neurotoxin complex (glabellar lines) (Package insert), Irvine, Calif.: Allergan, 2002.
3. Borodic, G. E., Ferrante, R., Pearce, L. B., et al. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov. Disord. 9: 31, 1994.
4. Garcia, A., and Fulton, J. E., Jr. Cosmetic denervation of the muscles of facial expression with botulinum toxin: A dose-response study. Dermatol. Surg. 22: 39, 1996.
5. Huang, W., Rogachefsky, A. S., and Foster, J. A. Browlift with botulinum toxin. Dermatol. Surg. 26: 55, 2000.
6. Matarasso, A., Matarasso, S. L., Brandt, F. S., et al. Botulinum A exotoxin for the management of platysma bands. Plast. Reconstr. Surg. 103: 645, 1999.